Ovarian cancer screening—Current status, future directions☆
Evidence of a mortality benefit continues to elude ovarian cancer (OC) screening. Data from the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial which used a screening strategy incorporating CA125 cut-off and transvaginal ultrasound has not shown mortality benefit. The United...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Academic Press
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991859/ |